News & Insights
COVID-19 Insights, Publications
Key Takeaways from the 2020 Virtual Health Care Investors Conference
October 1, 2020 | Firm Publication
COVID-19 Insights, Publications
Britt Latham and Brian Irving Analyze Potential for SEC Scrutiny of Public Companies Related to COVID-19
September 21, 2020 | Corporate Counsel
COVID-19 Insights, Publications
Key Takeaways from the Joint Venture Healthcare Transactions Dealmaker Perspectives Webinar
September 14, 2020 | Firm Publication
COVID-19 Insights, Publications
Recent SEC Comment Letters of Interest Regarding COVID-19 Adjustments, SAB 99 and South Korea
September 11, 2020 | Securities Law Exchange Blog
COVID-19 Insights, Publications
Updated Risk Factors in Response to COVID-19
August 27, 2020 | Securities Law Exchange Blog
COVID-19 Insights, Publications
SBA Releases New Guidance on PPP Loan Forgiveness
August 5, 2020 | Firm Publication
COVID-19 Insights, Publications
Approaching COVID-19 Risk Factor Disclosure in Upcoming Quarterly Reports on Form 10-Q
July 22, 2020 | Securities Law Exchange Blog
COVID-19 Insights, Media Mentions
Attorneys Discuss Healthcare M&A Landscape in the Wake of COVID-19 on Deal Talk with 7MA Podcast
July 21, 2020 | Deal Talk with 7MA Podcast
COVID-19 Insights, Publications
Jon Stanley Examines Representations and Warranties Insurance in M&A During COVID-19 Pandemic
July 13, 2020 | ValueWalk, ValueWalk ValueTalks Podcast
COVID-19 Insights, Publications
Key Takeaways from Manufacturing Dealmaker Perspectives Webinar
July 6, 2020 | Firm Publication